Vas Narasimhan, Novartis CEO (Akio Kon/Bloomberg via Getty Images)
Novartis CEO plays down Cytokinetics buyout rumors in CNBC interview
Novartis CEO Vas Narasimhan threw cold water on the rumors about his company’s potential acquisition of the biotech Cytokinetics.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
